Volume | 25,057 |
---|---|
Market Cap (ZAR m) | 1,345 |
Day High | 160 |
---|---|
Day Low | 160 |
Share Name | AFRO-C |
---|---|
Code | ACT |
Short Name | AFRO-C |
Long Name | AFROCENTRIC INV CORP LTD |
JSE Sector | HEALTH CARE SERVICES |
AGM Date | Monday, 12 May 2025 |
P/E Ratio (x) | 5.17 |
---|---|
Earnings Yield (%) | 19.35 |
Dividend Yield (%) | 6.00 |
Bid | 131 |
Ask | 170 |
Business |
---|
Afrocentric Investment Corp Ltd is a black-owned investment holding company with an investment portfolio focused on services to the healthcare sector. It seeks to invest in healthcare-related businesses that demonstrate prospects for growth as well as diversify its revenue sources while contributing to the sustainable health and welfare of South African communities. The company provides health administration and health risk management solutions to the healthcare industry. Its operating segments include: Healthcare SA; Healthcare Retail; Healthcare Africa and Information Technology. The geographical segments include businesses outside of South Africa which include Botswana, Mauritius and Namibia. |
Type | ETDDeclared Date | LTDLast Trade Date | Pay Date | Amount (ZAR) |
---|---|---|---|---|
Final No 23 | 04/03/2025 | 06/05/2025 | 12/05/2025 | 0.0600 |
Interim No 22 | 04/03/2024 | 07/05/2024 | 13/05/2024 | 0.1100 |
Final No 21 | 13/09/2022 | 08/11/2022 | 14/11/2022 | 0.1700 |
Interim No 20 | 15/03/2022 | 10/05/2022 | 16/05/2022 | 0.1700 |
Final No 19 | 14/09/2021 | 09/11/2021 | 15/11/2021 | 0.1700 |
Interim No 18 | 09/03/2021 | 11/05/2021 | 17/05/2021 | 0.1700 |
Data is for information purposes only and does not constitute advice.
A consensus forecast figure is normally an average or median of all the estimates from individual analysts tracking a particular share. Based on projections, models, sentiments and research, analysts strive to come up with an estimate of what the company will do in the future.Consensus estimates are not an exact science. All reports rely not only on financial statements which may be manipulated by management or other staff, with access to company records - they also involve inputs, such as footnotes, management commentary, research into the industry overall, peer companies, and macroeconomic analysis. Generally, ratings from shares that have wide analyst coverage could be deemed more robust than those that have narrow analyst coverage.If a company exceeds consensus estimates, it is usually rewarded with an increase in its share price. If a company falls short of consensus numbers - or sometimes if it only meets expectations - its share price can fall. The date the forecast was made is important, as if the share has moved considerably since then, the rating may no longer apply.
Price(c) at 17/09/2025 | 160 | |||
High/Low Price(c) (12 Months) | 300 / 110 | |||
P/E at 17/09/2025 | 5.17 | |||
High/Low ACT P/E (12 Months) | 23.55 / 3.35 | |||
High/Low Index P/E (12 Months) | 0 / 0 | |||
EARNINGS FORECAST (17/09/2025) | CURRENT | 2026 | 2027 | |
---|---|---|---|---|
Earnings Yield percentage (EY%) | 19.35 | N/A | N/A | |
Price-earnings ratio (P/E) | 5.17 | N/A | N/A | |
Earnings(c) per share (EPS) | 31 | N/A | N/A | |
Pct Change prev year (%) | N/A | N/A | ||
DIVIDEND FORECAST (17/09/2025) | CURRENT | 2026 | 2027 | |
Dividend Yield percentage (DY%) | 6.00 | 3.8 | 7.5 | |
Dividends(c) per share (DPS) | 10 | 6 | 12 |